Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04722172
Title A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Basking Ridge (All protocol activities) Basking Ridge New Jersey 07920 United States Details
Hackensack Meridian Health (Data collection only) Hackensack New Jersey 07601 United States Details
Memorial Sloan Kettering Monmouth (All protocol activities) Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (All protocol activities) Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack (All protocol activities) Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester (All protocol activities) Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York New York 10065 United States Details
Memorial Sloan Kettering Nassau (All protocol activities) Uniondale New York 11553 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field